Hope for Stretch Marks!
Lux1540™
Fractional Laser Receives FDA Approval for Treatment of Stretch Marks
Our Palomar
Lux1540™ Fractional non-ablative laser handpiece has received the first
clearance by the FDA for
the treatment of striae (stretch marks) using a fractional laser. This
new clearance will allow us to treat women who have unwanted stretch marks.
Ongoing clinical studies have shown that subjects treated with the
Lux1540™ achieved an average improvement of between 51% and 75% in the
appearance of their striae, based upon a blinded review of photographs
comparing the pre-treatment appearance of striae versus the results
three months post-treatment.
This new clearance expands the broad range of treatments offered by
the Lux1540™, which may be used to treat surgical scars, acne scars, and
melasma, as well as offer non-ablative skin resurfacing.
____________________________________________________________________________________
New! SelphylTM
Alternative to Dermal Fillers
Selphyl is NOT a dermal filler. It is a patented system for the
safe and rapid preparation of Platelet-rich Fibrin Matrix (PRFM) that
is a proven technology to correct the signs of skin aging. In our
office, we will collect a small amount of your blood and through a
patented process, we will separate your platelets and fibrin. This PRFM
is then injected into the desired areas such as the nasolabial folds of
your face.
Unlike dermal fillers that use a variety of synthetic substances,
Selphyl PRFM uses your natural biology to address skin defects and
volume loss by harnessing the power of the platelets naturally derived
from your blood. There are no animal or synthetic components in Selphyl.
Although not permanent, Selphyl PRFM offers natural and lasting
effects; however, it can take up to three weeks to see the gradual,
sustained volume gain. Another benefit is that it causes improvement in the appearance of the overlying skin.
Need more information? Schedule a
complimentary consultation today, or visit
Selphyl's website.
____________________________________________________________________________________